The costs and impacts of alternative HIV treatment strategies for patients on ART: A Collaborative Analysis

Abstract: In 2013 the World Health Organization HIV/AIDS Department will publish new treatment guidelines for HIV/AIDS.  The new guidelines will differ from previous guidelines by being the first to make recommendations beyond clinical management to include operational and programmatic considerations.
 
The HIV Modelling Consortium leads the coordinated interaction between modelling groups and policy-makers engaged in HIV/AIDS, with a particular focus on low and middle income countries.
 
The World Health Organization has tasked the HIV Modelling Consortium to collate evidence from modelling and economic evaluation studies, and to undertake new analyses, to inform the HIV treatment recommendations.  The key issues that are being investigated are: (a) when to start antiretroviral therapy (ART), and (b) how to monitor patients on ART.
 
Dr. Tim Hallett will present work from the HIV Modelling Consortium that is being used in the deliberations of the WHO Clinical and Programmatic Guideline Committees to inform the new treatment guidelines.